Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Renin-angiotensin system inhibitors and angioedema: anesthetic implications.

Stojiljkovic L.

Curr Opin Anaesthesiol. 2012 Jun;25(3):356-62. doi: 10.1097/ACO.0b013e328352dda5. Review.

PMID:
22552531
2.

Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series.

Bas M, Greve J, Stelter K, Bier H, Stark T, Hoffmann TK, Kojda G.

Ann Emerg Med. 2010 Sep;56(3):278-82. doi: 10.1016/j.annemergmed.2010.03.032. Epub 2010 May 5.

PMID:
20447725
3.

Icatibant: a novel approach to the treatment of angioedema related to the use of angiotensin-converting enzyme inhibitors.

Gallitelli M, Alzetta M.

Am J Emerg Med. 2012 Oct;30(8):1664.e1-2. doi: 10.1016/j.ajem.2011.09.014. Epub 2011 Nov 17.

PMID:
22100478
4.

[Icatibant is a new treatment option in life-threatening angioedema triggered by angiotensin-converting enzyme inhibitor].

Fast S, Henningsen E, Bygum A.

Ugeskr Laeger. 2011 Oct 10;173(41):2574-5. Danish.

PMID:
21985837
5.

Angioedema: etiology, pathophysiology, current and emerging therapies.

Lewis LM.

J Emerg Med. 2013 Nov;45(5):789-96. doi: 10.1016/j.jemermed.2013.03.045. Epub 2013 Aug 29. Review.

PMID:
23992848
6.

Icatibant in angiotensin-converting enzyme (ACE) inhibitor-associated angioedema.

Fok JS, Katelaris CH, Brown AF, Smith WB.

Intern Med J. 2015 Aug;45(8):821-7. doi: 10.1111/imj.12799.

PMID:
25944565
7.

Brief review: angiotensin converting enzyme inhibitors and angioedema: anesthetic implications.

Sarkar P, Nicholson G, Hall G.

Can J Anaesth. 2006 Oct;53(10):994-1003. Review.

PMID:
16987854
8.

Pharmacologic management of angioedema induced by angiotensin-converting enzyme inhibitors.

Scalese MJ, Reinaker TS.

Am J Health Syst Pharm. 2016 Jun 15;73(12):873-9. doi: 10.2146/ajhp150482. Review.

PMID:
27261237
9.

Nonallergic angioedema: role of bradykinin.

Bas M, Adams V, Suvorava T, Niehues T, Hoffmann TK, Kojda G.

Allergy. 2007 Aug;62(8):842-56. Review.

10.

[Upper airway obstruction caused by ACE inhibitor-induced angioedema].

Kongstad T, Islander G.

Lakartidningen. 2012 Apr 4-10;109(14-15):758-61. Swedish. No abstract available.

PMID:
22611881
11.

[Angiotensin-converting enzyme inhibitor induced angioedema : new therapy options].

Bas M, Kojda G, Stelter K.

Anaesthesist. 2011 Dec;60(12):1141-5. doi: 10.1007/s00101-010-1798-3. Epub 2010 Oct 6. German.

PMID:
20922352
12.

The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED.

Bartal C, Zeldetz V, Stavi V, Barski L.

Am J Emerg Med. 2015 Mar;33(3):479.e1-3. doi: 10.1016/j.ajem.2014.08.055. Epub 2014 Aug 27.

PMID:
25241359
13.

Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema.

Byrd JB, Touzin K, Sile S, Gainer JV, Yu C, Nadeau J, Adam A, Brown NJ.

Hypertension. 2008 Jan;51(1):141-7. Epub 2007 Nov 19.

14.

Icatibant and ACE inhibitor angioedema.

Illing EJ, Kelly S, Hobson JC, Charters S.

BMJ Case Rep. 2012 Aug 30;2012. pii: bcr2012006646. doi: 10.1136/bcr-2012-006646.

15.

Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant.

Del Corso I, Puxeddu I, Sardano E, Geraci S, Breggia M, Rocchi V, Migliorini P.

Ann Allergy Asthma Immunol. 2012 Jun;108(6):460-1. doi: 10.1016/j.anai.2012.03.013. Epub 2012 Apr 10. No abstract available.

PMID:
22626601
16.

Angiotensin-converting enzyme inhibitor-related angioedema: how to deal with it.

Beltrami L, Zingale LC, Carugo S, Cicardi M.

Expert Opin Drug Saf. 2006 Sep;5(5):643-9. Review.

PMID:
16907654
17.

Drug-induced angioedema.

Lerch M.

Chem Immunol Allergy. 2012;97:98-105. doi: 10.1159/000335621. Epub 2012 May 3.

PMID:
22613856
18.

[Treatment of drugs-associated non-hereditary angioedema mediated by bradykinin].

Muller Y, Harr T.

Rev Med Suisse. 2016 Jan 13;12(500):11-2. French.

PMID:
26946694
19.

Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.

Tschöpe C, Seidl U, Reinecke A, Riester U, Graf K, Schultheiss HP, Hilgenfeldt U, Unger T.

Int Immunopharmacol. 2003 Mar;3(3):335-44.

PMID:
12639811
20.

Angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter review and an algorithm for airway management.

Chiu AG, Newkirk KA, Davidson BJ, Burningham AR, Krowiak EJ, Deeb ZE.

Ann Otol Rhinol Laryngol. 2001 Sep;110(9):834-40.

PMID:
11558759

Supplemental Content

Support Center